Riskpilot← Back to searchSign inGet full accessRefunction AB
ABActiveOrg 5592837982Dansutvägen 2Physiotherapy activities · NACE 8695Est. 20200 employees
Revenue 2024
SEK 140K
-72% vs 2023
EBITDA margin
-100.7%
-269% vs 2023
Equity ratio
65.0%
Financial strength
Net profit 2024
SEK -103K
-530% vs 2023
| Revenue | SEK 140K | -72% |
| EBITDA | SEK -141K | -269% |
| Net profit | SEK -103K | -530% |
| Total assets | SEK 53K | -79% |
| Equity | SEK 34K | -75% |
| Employees | 0 | — |
Legal name
Refunction AB
Org number
5592837982
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
18 november 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Rehabiliteringsklinik inom primärvården. Diagnostisera och behandla åkommor i Rörelseapparaten. Erbjuda Tjänster inom: Kiropraktik. Fysioterapi. Övriga tjänster inom friskvården. Samt försäljning av produkter inom dessa områden.
Address
Dansutvägen 2
Email
carl.klofverskjold@proton.me
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 452 | 1 130 | 503 | 140 |
| Staff expenses | — | −458 | −89 | −16 |
| EBITDA | −7 | 172 | 84 | −141 |
| Depreciation & amort. | −14 | −41 | −41 | — |
| EBIT | −21 | 131 | 43 | −141 |
| Net financials | — | 0 | 0 | −1 |
| Profit before tax | −21 | 103 | 31 | −103 |
| Tax | −0 | −15 | −7 | — |
| Net profit | −21 | 88 | 24 | −103 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 364 | 265 | 249 | 53 |
| Equity | 304 | 113 | 137 | 34 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 60 | 124 | 72 | 18 |
| Total debt | 60 | 124 | 72 | 18 |
EBITDA margin
-100.7%
This company
15.8%
Market median
-737% vs market
20212024
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20212024
Return on equity
-300.2%
This company
18.4%
Market median
-1732% vs market
20212024
Net profit margin
-73.4%
This company
8.1%
Market median
-1006% vs market
20212024
Asset turnover
2.66×
This company
1.12×
Market median
+138% vs market
20212024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Refunction AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Gustav Stefan Klöfverskjöld | Board of Directors | 0 companies |
| Rebecca Marie Klöfverskjöld | Deputy Board Member | 0 companies |